CLOs on the Move

Galectin Therapeutics

www.galectintherapeutics.com

 
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company`s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Myonexustx

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first-ever, corrective treatments for Limb-girdle muscular dystrophy.

AltaThera Pharmaceuticals

AltaThera Pharmaceuticals is a Chicago-based specialty pharmaceutical company focused on identifying, acquiring, developing, and commercializing therapies addressing unmet medical needs of critical care patients and those with severe, and often rare, disorders for which few effective treatments are available.

Valeant Canada Limited

Valeant Canada Limited is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ivantis

Help control your eye pressure and possibly reduce your need for Glaucoma medication with the Hydrus® Microstent.

Elk Hill

Elk Hill enables children and families to transform overwhelming challenges into successful futures by offering behvioral health and education services.